Nicholas Kadysh, a erstwhile Red Bull Canada and Juul Labs Canada executive, is an adept connected regulatory issues
VANCOUVER, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE: CWY) (“Clearmind” oregon the "company"), a biotech institution focused connected find and improvement of caller psychedelic-derived therapeutics to lick large undertreated wellness problems, contiguous announced the assignment of seasoned regulatory enforcement Nicholas Kadysh arsenic peculiar advisor for the improvement of MEAI arsenic an intoxicant substitute.
Kadysh, a erstwhile enforcement astatine Red Bull Canada and Juul Labs Canada, is simply a vocation adept connected navigating analyzable regulatory challenges successful the wellness and nutrient industry. He is the laminitis of PharmAla Biotech, which manufactures MDMA- and MDXX-class molecules for pharmaceutical research, and the Board Chair of Psychedelics Canada, the commercialized relation for the for-profit, ineligible Canadian psychedelics industry.
"Nick brings invaluable cognition of firm affairs and regulations. We are thrilled to person him articulation the institution and lend from his immense acquisition to our intoxicant substitute program," said Dr. Adi Zuloff- Shani, Clearmind's Chief Executive Officer.
In parallel to processing its innovative caller psychedelic-derived cause campaigner MEAI for treating addictions, Clearmind is besides gathering a parallel way successful which MEAI is deployed arsenic an intoxicant substitute. The institution is presently preforming the information studies for this.
According to NielsenIQ, a planetary accusation services company, non-alcoholic beverage income are increasing quickly. Between August 2021 and August 2022, full dollar income of non-alcoholic drinks successful the US stood astatine $395 cardinal -- a year-on-year maturation of astir 21%.
About Clearmind Medicine Inc.
Clearmind Medicine (Nasdaq: CMND), (CSE: CMND), (FSE: CWY), is simply a biotech institution focused connected the find and improvement of caller psychedelic-derived therapeutics to lick wide and underserved wellness problems. The company’s flagship patented molecule MEAI is being researched arsenic a imaginable solution for intoxicant addiction and has already demonstrated aboriginal grounds of curbing binge behaviors that tin pb to intoxicant and cause abuse. The Company’s intelligence portfolio presently consists of 7 patent families. The company’s superior nonsubjective is to probe and make psychedelic-based compounds and commercialize them arsenic regulated medicine, foods oregon supplements.
For further accusation visit: https://www.clearmindmedicine.com oregon contact:
Investor Relations
invest@clearmindmedicine.com
Telephone: (604) 260-1566
General Inquiries
Info@Clearmindmedicine.com
www.Clearmindmedicine.com
FORWARD-LOOKING STATEMENTS:
This property merchandise contains “forward-looking statements” wrong the meaning of the Private Securities Litigation Reform Act and different securities laws. Words specified arsenic “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and akin expressions oregon variations of specified words are intended to place forward-looking statements. For example, the Company is utilizing forward-looking statements erstwhile it discusses objective batches accumulation of its caller psychedelic-derived cause candidate, the Company's upcoming FIH objective trial, and immoderate aboriginal correspondence with the FDA. Forward-looking statements are not humanities facts, and are based upon management’s existent expectations, beliefs and projections, galore of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed successful bully faith. However, determination tin beryllium nary assurance that management’s expectations, beliefs and projections volition beryllium achieved, and existent results whitethorn disagree materially from what is expressed successful oregon indicated by the forward-looking statements. Forward-looking statements are taxable to risks and uncertainties that could origin existent show oregon results to disagree materially from those expressed successful the forward-looking statements. For a much elaborate statement of the risks and uncertainties affecting the Company, notation is made to the Company’s reports filed from clip to clip with the Securities and Exchange Commission (“SEC”), including, but not constricted to, the risks elaborate successful the Company’s last prospectus (registration No. 333-265900) filed with the SEC connected November 16, 2022. Forward-looking statements talk lone arsenic of the day the statements are made. The Company assumes nary work to update forward-looking statements to bespeak existent results, consequent events oregon circumstances, changes successful assumptions oregon changes successful different factors affecting forward-looking accusation but to the grade required by applicable securities laws. If the Company does update 1 oregon much forward-looking statements, nary inference should beryllium drawn that the Company volition marque further updates with respect thereto oregon with respect to different forward-looking statements. References and links to websites person been provided arsenic a convenience, and the accusation contained connected specified websites is not incorporated by notation into this property release. Clearmind is not liable for the contents of third-party websites.
English (US)